FDA Clears GenesisX Robotic Magnetic Navigation System for Minimally Invasive Endovascular Interventions
ByAinvest
Monday, Nov 10, 2025 4:11 pm ET1min read
STXS--
Stereotaxis has received FDA clearance for its GenesisX robotic magnetic navigation system, which features a compact design and operates on standard power. The system allows for easy installation in existing cath labs without complex architectural planning or construction. GenesisX is the latest advance in endovascular surgical robotics and has the potential to increase accessibility and scalability of Robotic Magnetic Navigation. Stereotaxis has initiated a limited launch in the US and Europe and plans to expand its portfolio of compatible catheters and enhance commercial processes.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet